Skip to main content
Satish Shanbhag, MD, Oncology, Fleming Island, FL, HCA Florida Orange Park Hospital

SatishPramodShanbhagMD

Oncology Fleming Island, FL

Hematologic Oncology

Physician

Dr. Shanbhag is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shanbhag's full profile

Already have an account?

Summary

  • Dr. Satish Shanbhag is an oncologist in Fleming Island, FL and is affiliated with Ascension St. Vincent's Medical system and HCA Florida Orange Park Hospital. He received his medical degree from Bangalore Medical College and has been in practice 15 years. He also speaks multiple languages, including Hindi. He specializes in hematology and oncology with additional expertise in leukemia, lymphoma and myeloma. He has more than 40 publications and over 500 citings.

Education & Training

  • Temple University Hospital
    Temple University HospitalFellowship, Hematology and Medical Oncology, 2007 - 2010
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Bangalore Medical College
    Bangalore Medical CollegeClass of 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2019 - 2026
  • MD State Medical License
    MD State Medical License 2010 - 2021
  • PA State Medical License
    PA State Medical License 2007 - 2010
  • AL State Medical License
    AL State Medical License 2004 - 2007
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Journal Articles

  • Pembrolizumab in Mycosis Fungoides and Sézary Syndrome: Updated Results of the CITN Multicenter Phase 2 Study  
    Michael S Khodadoust, Pierluigi Porcu, Francine Foss, Andrei R Shustov, Satish Shanbhag, Lubomir Sokol, Steven M Horwitz, Elad Sharon, European Journal of Cancer

Lectures

  • Potentiating the Power of Platelets: Examining the Clinical Utility of Multiple Thrombopoietin Receptor Agonists in ITP, Chemotherapy Induced Thrombocytopenia and Live... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Authored Content

  • Brentuximab Vedotin for Frontline Hodgkin Lymphoma: How Much Will a Successful Trial Cost Patients and Payers?October 2018

Other Languages

  • Hindi

Hospital Affiliations